Gene signature of glioblastoma identified

A group of immune genes have been identified that may be key in controlling cancerous spread and survival times of patients with glioblastoma multiforme, a new Neurology study has revealed. The study could have implications for survival of patients with this form of brain tumor and who currently only live for on average less than 2 years following treatment. “We’ve had luck with other types of cancer in removing the brakes on the immune system to allow it to fight the tumors, but this has not been the case with glioblastoma,” explained study author Anhua Wu (First Hospital of China...